Lac Med lists on the Main Market of Bursa Malaysia

SELANGOR (Dec 10): Leading medical devices and integrated solutions provider, Lac Med Bhd (Lac Med) is charting its next phase of growth with a broader portfolio of medical devices and solutions to cater to the growing healthcare sector in Malaysia, while extending its presence in Indonesia to add new overseas revenue stream to the group.

This comes as Lac Med made its debut on the Main Market of Bursa Malaysia Securities Berhad.

Since 2023, Lac Med has added nine international brands to its portfolio, bringing the total to 11, reinforcing the Groupís growth trajectory.

Currently, Lac Medís portfolio covers radiographic equipment, ultrasound and MRI machines, medical consumables, software, and systems. With a wide array of offerings, the group is well equipped to enable healthcare service providers to deliver services more efficiently, ensuring patients receive timely and quality care.

Lac Med group chief executive officer, Liew Yoon Poh said, ìThis listing on the Main Market of Bursa Malaysia Securities Berhad marks a pivotal moment for Lac Med. We experienced significant growth in the second decade of our journey, building a strong presence as a leading provider of radiographic and ultrasound machines through just two authorised brands previously.

“As we enter the next phase with a portfolio of 11 authorised brands, we are well-poised to advance further, supported by a wider and more diversified range of offerings to propel our performance.”

To strengthen our position as one of Malaysiaís market leaders, the group aims to drive AI-powered and digital solutions to advance the nationís healthcare sector.

“Beyond Malaysia, we are pursuing new growth opportunities in Indonesia. We will leverage our two decades of experience and strong brand portfolio to mirror the success we have achieved in Malaysia and translate it into sustainable growth in the Indonesian market,” Liew said.

With an established track record built over two decades, Lac Med has served 217 hospitals nationwide, commanding a market coverage of 58 per cent.

These healthcare service providers include IHH Healthcare Group, Sunway Healthcare Group, Columbia Asia, MAHSA Hospital, and many more. Beyond hospitals, the group has also serviced over 800 clinics across Malaysia.

Lac Med also aims to leverage its extensive experience to accelerate its expansion into Indonesia. According to the Indonesian Ministry of Health, the country had 3,228 hospitals, 10,268 public health centres, and 20,693 private clinics in 2024.

The scale of Indonesiaís healthcare network provides a substantial demand base for medical device distribution, positioning Lac Med to capture new opportunities in the region.

RHB Investment Bank Berhad is the principal adviser, joint underwriter and sole placement agent for the IPO, while Alliance Islamic Bank Berhad is the joint underwriter.